These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8963765)

  • 21. Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck.
    Kim SH; Wong RJ; Kooby DA; Carew JF; Adusumilli PS; Patel SG; Shah JP; Fong Y
    Eur J Cancer; 2005 Jan; 41(2):313-22. PubMed ID: 15661558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination nonviral interleukin 2 gene therapy and external-beam radiation therapy for head and neck cancer.
    Bray D; Yu SZ; Koprowski H; Rhee J; Kumar S; Pericle F; Suntharalingam M; Van Echo DA; Li D; O'Malley BW
    Arch Otolaryngol Head Neck Surg; 2003 Jun; 129(6):618-22. PubMed ID: 12810463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison in strategies for advanced head and neck squamous cell carcinomas between Japan and western countries].
    Tsukuda M
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):54-60. PubMed ID: 9987498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current role of gene therapy in head and neck cancer.
    Ganly I; Soutar DS; Kaye SB
    Eur J Surg Oncol; 2000 Jun; 26(4):338-43. PubMed ID: 10873352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integration of conventional and immune therapy in the treatment of head and neck squamous carcinomas: a rational approach for the development of new protocols.
    Chretien PB
    Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):83-4. PubMed ID: 619217
    [No Abstract]   [Full Text] [Related]  

  • 26. Is there still a role for induction chemotherapy for head and neck cancer?
    Garden AS
    J Clin Oncol; 2005 Feb; 23(6):1059-60. PubMed ID: 15657407
    [No Abstract]   [Full Text] [Related]  

  • 27. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
    Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE
    Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma.
    Strome SE; Dong H; Tamura H; Voss SG; Flies DB; Tamada K; Salomao D; Cheville J; Hirano F; Lin W; Kasperbauer JL; Ballman KV; Chen L
    Cancer Res; 2003 Oct; 63(19):6501-5. PubMed ID: 14559843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Quality of life after simultaneous radiochemotherapy in squamous cell carcinoma of the head and neck].
    Wendt TG
    Strahlenther Onkol; 2000 Apr; 176(4):198-200. PubMed ID: 10812396
    [No Abstract]   [Full Text] [Related]  

  • 30. Combined IL-2 and IL-12 gene therapy for murine head and neck squamous cell carcinoma.
    Liu S; Yang H; Liang C
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):323-6. PubMed ID: 12408755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Head and neck squamous cell carcinomas.
    Fayette J
    Anticancer Drugs; 2011 Aug; 22(7):585. PubMed ID: 21705866
    [No Abstract]   [Full Text] [Related]  

  • 32. Adjuvant intralesional and systemic Corynebacterium parvum immunotherapy for surgically treated head and neck cancer.
    Beatty JD; Terz JJ; Brown PW; Lawrence W; Schuller GB; Kaplan AM
    Surg Forum; 1978; 29():155-7. PubMed ID: 401122
    [No Abstract]   [Full Text] [Related]  

  • 33. Surgical wound complications after intensive chemoradiotherapy for advanced squamous cell carcinoma of the head and neck.
    Morgan JE; Breau RL; Suen JY; Hanna EY
    Arch Otolaryngol Head Neck Surg; 2007 Jan; 133(1):10-4. PubMed ID: 17224515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregnancy and head and neck malignancy.
    Bahadur S; Bindra GS; Bhatia R; Rath GK
    Indian J Cancer; 1986 Mar; 23(1):64-8. PubMed ID: 3817863
    [No Abstract]   [Full Text] [Related]  

  • 36. Head and neck cancer. Introduction.
    Brizel DM
    Semin Radiat Oncol; 2009 Jan; 19(1):1-2. PubMed ID: 19028338
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification of molecular targets for immunotherapy of patients with head and neck squamous cell carcinoma.
    Dasgupta S; Tripathi PK; Qin H; Bhattacharya-Chatterjee M; Valentino J; Chatterjee SK
    Oral Oncol; 2006 Mar; 42(3):306-16. PubMed ID: 16321566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy of head and neck cancer.
    Resser JR; Carbone DP
    Curr Opin Oncol; 1998 May; 10(3):226-32. PubMed ID: 9619359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma.
    Nakano H; Kishida T; Asada H; Shin-Ya M; Shinomiya T; Imanishi J; Shimada T; Nakai S; Takeuchi M; Hisa Y; Mazda O
    J Gene Med; 2006 Jan; 8(1):90-9. PubMed ID: 16097036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination nonviral cytokine gene therapy for head and neck cancer.
    Li D; Zeiders JW; Liu S; Guo M; Xu Y; Bishop JS; O'Malley BW
    Laryngoscope; 2001 May; 111(5):815-20. PubMed ID: 11368072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.